Companies / Colombia
Colombia Mulls Cuban Drug Production
June 2006 | Company Finance AlertLeishmaniasis drug Impavido (miltefosine), produced by Canadian biotech Aeterna Zentaris, was approved in March 2005. It is currently marketed by Tecnofarma in all Latin American countries except
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
